|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS: | ||||||||||||||||
| Cash and due from banks | ||||||||||||||||
| Interest earning deposits | ||||||||||||||||
| Total cash and cash equivalents | ||||||||||||||||
| Securities available-for-sale, at fair value | ||||||||||||||||
| Investment securities held-to-maturity (fair value 2022-$1,301, 2021-$1,721) | ||||||||||||||||
| Interest-earning time deposits in banks | ||||||||||||||||
| Investment securities available-for-sale, at fair value | ||||||||||||||||
| Investment securities held-to-maturity (fair value 2024-$1,192, 2023-$1,226) | ||||||||||||||||
| Equity investment securities, at fair value | ||||||||||||||||
| Federal Home Loan Bank stock, at cost | ||||||||||||||||
| Loans | ||||||||||||||||
| Less: Allowance for credit losses | ||||||||||||||||
| Loans receivable, net | ||||||||||||||||
| Premises and equipment, net | ||||||||||||||||
| Bank-owned life insurance | ||||||||||||||||
| Pension plan asset | ||||||||||||||||
| Foreclosed real estate | ||||||||||||||||
| Goodwill | ||||||||||||||||
| Intangible assets, net | ||||||||||||||||
| Accrued interest receivable | ||||||||||||||||
| Other assets | ||||||||||||||||
| Total assets | ||||||||||||||||
| LIABILITIES AND SHAREHOLDERS' EQUITY: | ||||||||||||||||
| Deposits: | ||||||||||||||||
| Noninterest-bearing | ||||||||||||||||
| Interest-bearing | ||||||||||||||||
| Total deposits | ||||||||||||||||
| Short-term borrowings | ||||||||||||||||
| Long-term borrowings | ||||||||||||||||
| Advances from borrowers for taxes and insurance | ||||||||||||||||
| Deferred tax liability | ||||||||||||||||
| Other liabilities | ||||||||||||||||
| Total liabilities | ||||||||||||||||
| Shareholders' equity: | ||||||||||||||||
| Common stock, par value $0.01; 14,000,000 shares authorized in 2024 and 2023; 2,241,801 and 2,235,889 shares issued and outstanding at June 30, 2024 and December 31, 2023, respectively | ||||||||||||||||
| Additional paid in capital | ||||||||||||||||
| Retained earnings | ||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||
| Stock held in rabbi trust | ||||||||||||||||
| Unearned ESOP shares, at cost | ||||||||||||||||
| Total shareholders' equity | ||||||||||||||||
| Total liabilities and shareholders' equity | ||||||||||||||||
Loading...
